The biopharmaceutical and medical device industries are some of the most highly regulated industries in the world. Staying within regulatory compliance can take a lot of work regardless of a company’s maturity or size.
As your company expands to the global market, staying compliant and aware of the changing landscape becomes increasingly important for product quality and patient safety. But we’re all aware that there are nuances between different regulatory agencies.
Download our webinar, Comparing Inspection Observations between FDA and Health Canada, presented by Senior GXP Specialist Jason Kerr. He will evaluate data on pre-approval inspections, routine surveillance inspections, and for-cause inspections across the agencies and provide insights.
The webinar was held on Thursday, February 23, 2023, and the recording is a must for quality professionals to get up to speed on current trends and awareness of mitigating critical risks.
About the Speaker
As a G
XPSenior Specialist at Redica Systems, Jason Kerr is a member of our industry experts team, curating and enhancing our dataset. He previously worked at Amgen, monitoring global regulatory intelligence and identifying quality requirements to be triaged, assessed, and implemented to ensure compliance. His work also included designing and implementing a system to track changes being implemented and provide regular updates to key stakeholders. Jason holds a BS in Biochemistry from UCLA, a Master’s in Business and Science focused on Clinical and Regulatory Affairs from the Keck Graduate Institute, an MBA from the Quantic School of Business and Technology, and a certificate in Bioscience Industry Law and Practice from Southwestern Law School.
Get a Demo
We can show you insights into any of your key suppliers, FDA investigators, inspection trends, and much more.